Skip to main content
SpringerLink
Log in

Benzathine penicillin G for rheumatic fever prophylaxis: 2-Weekly versus 4-weekly regimens

  • Original Articles
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Rheumatic fever is still one of the major public health problems in Egypt and the developing countries. It is characterized by a high tendency to recur following streptococcal infections. The use of long acting penicillin for prophylaxis against strep infections was a good achievement in this field, yet, recurrences have been reported in patients following monthly prophylactic programs. Clinical experience in Alexandria have shown for a long time that giving penicillin every 2 weeks is followed by less recurrences of rheumatic fever. Recently, reports came showing that effective penicillin levels are not maintained except for 2 to 3 weeks after the injection.

In the present study, we compared two regimens of prophylaxis with 190 patients in the 2-weekly regimen, and 170 patients in the 4-weekly regimen being followed up for 2 consecutive years. Two hundred and sixty nine streptococcal infections occurred during this period. Although the streptococcal infection rate was equal in both groups, the rheumatic fever recurrence rate and the RF attack rate were significantly higher in the group of patients on the 4-weekly schedule. The results of this study have shown the superiority of the 2-weekly schedule in the adequate control of RF recurrences. We suggest that this schedule should be implemented for secondary prophylaxis of rheumatic fever in Egypt and other areas with severe RF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kassem AS, Badr Eldin M, Abdel Moneim MA. The pattern of rheumatic fever in Alexandria with 10 years follow up of the valvular lesions.Gazette Egypt Ped Assoc 1982; 30: 69–76.

    Google Scholar 

  2. Abdin ZH. An analytic study of rheumatic heart disease in Egyptian youth.Egypt Rheumatologist 1968; 5: 79–85.

    Google Scholar 

  3. El Sherif A. The epidemiological features of rheumatic fever and rheumatic heart disease in Egypt.Bull Egypt Soc Cardiol 1975; 14: 65–70.

    Google Scholar 

  4. Padmavati S, Shrestha NK. Problems of cardiovascular disease in Asia and Oceania. In: Hayase S, Murao S, MacArthur C, eds.Proceedings of the VIIIth World Congress of Cardiology, Tokyo, 1978. Amsterdam, Oxford, Princeton: Excerpta Medica, 1979: 49.

    Google Scholar 

  5. World Health Organization. Community control of rheumatic heart disease in the developing countries: 1. A major public health problem.WHO Chronicle 1980; 34: 336–345.

    Google Scholar 

  6. Padmavati S. Rheumatic fever and rheumatic heart disease in developing countries.Bull WHO 1978; 56(4): 543–550.

    PubMed  CAS  Google Scholar 

  7. Diehl AM, Hamilton TR, Keeling IC et al. Long acting repository penicillin in prophylaxis of recurrent rheumatic fever.JAMA 1954; 155: 1466–1470.

    CAS  Google Scholar 

  8. Committee on prevention of rheumatic fever and bacterial endocarditis. American Heart Association. Prevention of rheumatic fever and bacterial endocarditis through control of streptococcal infections.Circulation 1955; 11 (2): 317.

    Google Scholar 

  9. Committee report. The rheumatic fever committee of the council on rheumatic fever and congenital heart disease of the American Heart Association.Circulation 1971; 43; 983–988.

    Google Scholar 

  10. Committee on rheumatic fever and bacterial endocarditis. American Heart Association. Committee report. Prevention of rheumatic fever.Circulation 1977; 55(1): 1–4.

    Google Scholar 

  11. Wood HF, Feinstein AR, Taranta A et al. Rheumatic fever in children and adolescents. A long term epidemiological study of subsequent prophylaxis, streptococcal infections, and clinical sequelae. III. Comparative effectiveness of three prophylaxis regimens in preventing sterptococcal infections and rheumatic recurrences.Ann Int Med 1964; 60(2), Suppl 5: 31–46.

    Google Scholar 

  12. Sanyal SK, Berry AM, Duggal S et al. Sequelae of the initial attack of acute rheumatic fever in children from North India. A prospective 5-year follow-up study.Circulation 1982; 65(2): 375–379.

    PubMed  CAS  Google Scholar 

  13. Krause RM. Prevention of streptococcal sequelae by penicillin prophylaxis: A reassessment.J Infect Dis 1975; 131(5): 592–601.

    PubMed  CAS  Google Scholar 

  14. Strasser T, Dondog N, El-Kholy A et al. The community control of rheumatic fever and rheumatic heart disease: Report of a WHO international cooperative project.Bull WHO 1981 59(2): 285–294.

    PubMed  CAS  Google Scholar 

  15. Ginsburg CM, McCracken GH, Zweighaft TC. Serum penicillin concentrations after intramuscular administration of benzathine penicillin G in children.Pediatrics 1982; 69(4): 452–454.

    PubMed  CAS  Google Scholar 

  16. Saran RK, Sinha N, Ahuja RC et al. Serial serum penicillin levels following an injection of benzathine penicillin (12, lakh units) in children of rheumatic heart disease.Indian J Pediatr 1986; 53: 99–103.

    Article  PubMed  CAS  Google Scholar 

  17. Begue P, Fajac A, Girardet JP et al. Benzathine-benzylpenicilline dans la prophylaxie du rehumatisme articulaire aigu: Nouveau schema de prescription.La Presse Medicale 1988; 17(2): 82–83.

    PubMed  CAS  Google Scholar 

  18. Committee to revise the Jones Criteria of the council on rheumatic fever and congenital heart disease of the American Heart Association. Jones Criteria (Revised) for guidance in the diagnosis of rheumatic fever.Circulation 1965; 32: 664–666.

    Google Scholar 

  19. Gerber MA, Markowitz M. Management of streptococcal pharyngitis reconsidered.Pediatr Infect Dis 1985; 4(5): 518–526.

    PubMed  CAS  Google Scholar 

  20. Kaplan EL. Benzathine pencillin G for treatment of group A streptococcal pharyngitis: A reappraisal in 1985.Pediatr Infect Dis 1985; 4(5): 592–596.

    Article  PubMed  CAS  Google Scholar 

  21. Reynolds JEF, Prasad AB, eds.Martindale. The Extrapharma-copoeia. 28th edn. London: The Pharmaceutical Press, 1982: 1106.

    Google Scholar 

  22. Reyes AL, Tuazon-Mendoza M. Bravo LC, Tupasi TE. Control of rheumatic fever and rheumatic families II. Penicillin prophylaxis among rheumatic fever subjects comparing different regimens.Am J Med 1978; 16: 113–121.

    Google Scholar 

  23. Sinha N, Saran RK, Hasan M et al. Benzathine penicillin prophylaxis in juvenile rheumatic heart disease-3 weekly or 2 weekly injections.Indian Heart J 1984, 36: 315.

    Google Scholar 

  24. Zaher SR. Comparative study of 2 schedule of Penicillin Prophylaxis: 2-weeks vesus 4 weeks. Thesis, doctorate degree, University of Alexandria, 1989.

  25. MacDonald ME, Hagberg KL, Grossman BJ. Social factors in relation to participation in follow up care of rheumatic fever.J Pediatr 1963; 62: 503.

    Article  Google Scholar 

  26. Simon HJ, Sakai W. Staphylococal antagonism to penicillin-G therapy of hemolytic streptococcal pharyngeal infection. Effect of Oxacillin.Pediatrics 1963; 31(3): 463–469.

    PubMed  CAS  Google Scholar 

  27. Kaplan EL, Johnson DR. Eradication of group A streptococci from the upper respiratory tract by Amoxicillin with clavulanate after oral penicillin V treatment failure.J Pediatr 1988; 113(2): 400–403.

    Article  PubMed  CAS  Google Scholar 

  28. Lue HC et al. Clinical & epidemiological features of rheumatic fever and rheumatic heart disease in Taiwan and the Far East.Indian Heart J 1983; 35: 139–146.

    PubMed  CAS  Google Scholar 

  29. Majeed HA, Yousof AM, Khuffash FA et al. The natural history of acute rheumatic fever in Kuwait: A prospective six-year follow-up report.J Chronic Dis 1986; 39: 361–369.

    Article  PubMed  CAS  Google Scholar 

  30. Padmavati S, Gupta V, Prakash K, Sharma KB. Penicillin for rheumatic fever prophylaxis. 3-weekly or 4-weekly schedule?.J Assoc Phys India 1987; 35(11): 753–755.

    CAS  Google Scholar 

  31. Nordin JD. Recurrence of rheumatic fever during prophylaxis with monthly benzathine penicillin G.Pediatrics 1984; 73 (4): 530–531.

    PubMed  CAS  Google Scholar 

  32. Veasy LG, Wiedmeier SE, Orsmond GS et al. Resurgence of acute rheumatic fever in the intermountain area of the United States.N Engl J Med 1987; 316(8): 421–427.

    Article  PubMed  CAS  Google Scholar 

  33. Hosier DM et al. Resurgence of acute rheumatic fever.AJDC 1987; 141: 730.

    PubMed  CAS  Google Scholar 

  34. Krause RM. Prevention of streptococcal sequelae by penicillin prophylaxis: A reassessment.J Infectious Dis 1975; 131(5): 592–601.

    CAS  Google Scholar 

  35. Lue HC, Wu MH, Hsieh KH et al. Rheumatic fever recurrences: Controlled study of 3-week versus 4-week benzathine penicillin prevention programs.J Pediatr 1986; 108: 299–304.

    Article  PubMed  CAS  Google Scholar 

  36. Gordis L, Markowitz M, Lilienfeld AM. Why patients don't follow medical advice: A study of children on long term antistreptococcal prophylaxis.J Pediatr 1969; 75 (6): 957–968.

    Article  PubMed  CAS  Google Scholar 

  37. Arguelles E, Fiszman P, Fakoury L.Febre rheumatica e doencas valvulares do coracao. 2nd edn. Rio de Janeiro: Revinter, 1989: 143.

    Google Scholar 

  38. Markowitz M, Kaplan EL. Reappearance of rheumatic fever. In: Barness LA, ed.Advances in Pediatrics. Vol. 36. Chicago: Year Book Medical Publishers Inc., 1989: 39–65.

    Google Scholar 

  39. Kaplan EL, Berrios X, Speth J et al. Pharmakokinetics of benzathine penicillin G: serum levels during the 28 days after intramuscular injection of 1,200,000 units.J Pediatr 1989; 115: 146–150.

    Article  PubMed  CAS  Google Scholar 

  40. Ayoub EM. Prophylaxis in patients with rheumatic fever: Every three or every four weeks?.J Pediatr 1989; 115(1): 89–91.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics and Microbiology, University of Alexandria, 9 Abdel Hamid Eldib Street, Appt # 2-D, San Stefano-Alexandria, Egypt

    A. S. Kassem, A. A. Madkour, B. Z. Massoud & S. R. Zaher

Authors
  1. A. S. Kassem
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. A. Madkour
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Z. Massoud
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. R. Zaher
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kassem, A.S., Madkour, A.A., Massoud, B.Z. et al. Benzathine penicillin G for rheumatic fever prophylaxis: 2-Weekly versus 4-weekly regimens. Indian J Pediatr 59, 741–748 (1992). https://doi.org/10.1007/BF02859412

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02859412

Key words

Search

Navigation